CXCL12 Kit ELISA
-
- Antigène Voir toutes CXCL12 Kits ELISA
- CXCL12 (Chemokine (C-X-C Motif) Ligand 12 (CXCL12))
-
Reactivité
- Souris
- Méthode de détection
- Colorimetric
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 3-600 pg/mL
- Seuil minimal de détection
- 3 pg/mL
- Application
- ELISA
- Fonction
- Mouse SDF-1 alpha (CXCL12 alpha) ELISA Kit for cell culture supernatants, plasma, and serum samples.
- Type d'échantillon
- Plasma, Cell Culture Supernatant, Serum
- Analytical Method
- Quantitative
- Specificité
- This ELISA kit shows no cross-reactivity with any of the cytokines tested: Mouse CD30, L CD30, T CD40, CRG-2, CTACK, CXCL16, Eotaxin , Eotaxin-2, Fas Ligand, Fractalkine, GCSF, GM-CFS, IFN-gamma, IGFBP-3, IGFBP-5, IGFBP-6, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-3 Rb, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 p40/p70, IL-12 p70, IL-13, IL-17, KC, Leptin R, Leptin (OB), LIX, L-Selectin, Lymphotactin, MCP-1, MCP-5, MCSF, MIG, MIP-1 alpha, MIP-1 gamma, MIP-2, MIP-3 beta, MIP-3 alpha, PF-4, P-Selectin, RANTES, SCF, TARC, TCA-3, TECK, TIMP-1, TNF-alpha, TNF RI, TNF RII, TPO, VCAM-1, VEGF.
- Réactivité croisée (Details)
- This ELISA kit shows no cross-reactivity with any of the cytokines tested (e.g., Mouse CD30, L CD30, T CD40, CRG-2, CTACK, CXCL16, Eotaxin , Eotaxin-2, Fas Ligand, Fractalkine, GCSF, GM-CFS, IFN-gamma, IGFBP-3, IGFBP-5, IGFBP-6, IL-1 alpha, IL-1beta, IL-2, IL-3, IL-3 Rb, IL- 4, IL-5, IL-6, IL-9, IL-10, IL-12 p40/p70, IL-12 p70, IL-13, IL-17, KC, Leptin R, Leptin (OB), LIX, L-Selectin, Lymphotactin, MCP-1, MCP-5, M- CSF, MIG, MIP-1alpha, MIP-1gamma, MIP-2, MIP-3beta, MIP-3alpha, PF-4, P-Selectin, RANTES, SCF, TARC, TCA-3, TECK, TIMP-1, TNF-alpha, TNF RI, TNF RII, TPO, VCAM-1, VEGF).
- Sensibilité
- < 3 pg/mL
- Attributs du produit
-
- Strip plates and additional reagents allow for use in multiple experiments
- Quantitative protein detection
- Establishes normal range
- The best products for confirmation of antibody array data
- Ingrédients
-
- Pre-Coated 96-well Strip Microplate
- Wash Buffer
- Stop Solution
- Assay Diluent(s)
- Lyophilized Standard
- Biotinylated Detection Antibody
- Streptavidin-Conjugated HRP
- TMB One-Step Substrate
- Matériel non inclus
-
- Distilled or deionized water
- Precision pipettes to deliver 2 μL to 1 μL volumes
- Adjustable 1-25 μL pipettes for reagent preparation
- 100 μL and 1 liter graduated cylinders
- Tubes to prepare standard and sample dilutions
- Absorbent paper
- Microplate reader capable of measuring absorbance at 450nm
- Log-log graph paper or computer and software for ELISA data analysis
- Featured
- Discover our best selling CXCL12 Kit ELISA
- Top Product
- Discover our top product CXCL12 Kit ELISA
-
-
- Indications d'application
- Recommended Dilution for serum and plasma samples2 fold
- Volume d'échantillon
- 100 μL
- Plaque
- Pre-coated
- Protocole
-
- Prepare all reagents, samples and standards as instructed in the manual.
- Add 100 μL of standard or sample to each well.
- Incubate 2.5 h at RT or O/N at 4 °C.
- Add 100 μL of prepared biotin antibody to each well.
- Incubate 1 h at RT.
- Add 100 μL of prepared Streptavidin solution to each well.
- Incubate 45 min at RT.
- Add 100 μL of TMB One-Step Substrate Reagent to each well.
- Incubate 30 min at RT.
- Add 50 μL of Stop Solution to each well.
- Read at 450 nm immediately.
- Préparation des réactifs
-
- Bring all reagents and samples to room temperature (18 - 25 °C) before use.
2. Sample dilution: If your samples need to be diluted, Assay Diluent A (Item D) should be used for dilution of serum/plasma samples. 1x Assay Diluent B (Item E) should be used for dilution of culture supernatants. Suggested dilution for normal serum/plasma: 2 fold. Please note that levels of the target protein may vary between different specimens. Optimal dilution factors for each sample must be determined by the investigator.
3. Assay Diluent B should be diluted 5-fold with deionized or distilled water.
4. Preparation of standard: Briefly spin the vial of Item C. Add 600 µL Assay Diluent A (for serum/plasma samples) or 1x Assay Diluent B (for cell culture medium) into Item C vial to prepare 9 ng/mL standard solution. Dissolve the powder thoroughly by a gentle mix. Add 40 µL SDF-1alpha standard from the vial of Item C, into a tube with 560 µL Assay Diluent A or 1x Assay Diluent B to prepare a 600 pg/mL stock standard solution. Pipette 300 µL Assay Diluent A or 1x Assay Diluent B into each tube. Use the stock standard solution to produce a dilution series . Mix each tube thoroughly before the next transfer. Assay Diluent A or 1x Assay Diluent B serves as the zero standard (0 pg/mL). 40 µL standard + 560 µL 300 µL 300myl 300 µL 300 µL 300 µL 300 µL 600 300 150 75 37.5 18.75 9.38 0 pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL
5. If the Wash Concentrate (20x) (Item B) contains visible crystals, warm to room temperature and mix gently until dissolved. Dilute 20 ml of Wash Buffer Concentrate into deionized or distilled water to yield 400 ml of 1x Wash Buffer.
6. Briefly spin the Detection Antibody vial (Item F) before use. Add 100 µL of 1x Assay Diluent B into the vial to prepare a detection antibody concentrate. Pipette up and down to mix gently (the concentrate can be stored at 4 °C for 5 days). The detection antibody concentrate should be diluted 80-fold with 1x Assay Diluent B and used in step 4 of Part VI Assay Procedure.
7. Briefly spin the HRP-Streptavidin concentrate vial (Item G) and pipette up and down to mix gently before use. HRP-Streptavidin concentrate should be diluted 200-fold with 1x Assay Diluent B. For example: Briefly spin the vial (Item G) and pipette up and down to mix gently . Add 50 µL of HRP-Streptavidin concentrate into a tube with 10 ml 1x Assay Diluent B to prepare a 200-fold diluted HRP-Streptavidin solution (don't store the diluted solution for next day use). Mix well.
- Bring all reagents and samples to room temperature (18 - 25 °C) before use.
- Procédure de l'essai
-
- Bring all reagents and samples to room temperature (18 - 25 °C) before use. It is recommended that all standards and samples be run at least in duplicate.
2. Add 100 µL of each standard (see Reagent Preparation step 2) and sample into appropriate wells. Cover well and incubate for 2.5 hours at room temperature or over night at 4 °C with gentle shaking.
3. Discard the solution and wash 4 times with 1x Wash Solution. Wash by filling each well with Wash Buffer (300 myl) using a multi-channel Pipette or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.
4. Add 100 µL of 1x prepared biotinylated antibody (Reagent Preparation step 6) to each well. Incubate for 1 hour at room temperature with gentle shaking.
5. Discard the solution. Repeat the wash as in step
6. Add 100 µL of prepared Streptavidin solution (see Reagent Preparation step 7) to each well. Incubate for 45 minutes at room temperature with gentle shaking.
7. Discard the solution. Repeat the wash as in step
8. Add 100 µL of TMB One-Step Substrate Reagent (Item H) to each well. Incubate for 30 minutes at room temperature in the dark with gentle shaking.
9. Add 50 µL of Stop Solution (Item I) to each well. Read at 450 nm immediately.
- Bring all reagents and samples to room temperature (18 - 25 °C) before use. It is recommended that all standards and samples be run at least in duplicate.
- Calcul des résultats
-
Calculate the mean absorbance for each set of duplicate standards, controls and samples, and subtract the average zero standard optical density. Plot the standard curve on log-log graph paper or using Sigma plot software, with standard concentration on the x-axis and absorbance on the y-axis. Draw the best-fit straight line through the standard points.
Typical Data: These standard curves are for demonstration only. A standard curve must be run with each assay. Assay Diluent A Mouse SDF-1-alpha concentration (pg/mL) 1 10 100 1000 O D =4 50 n m 0.01 0.1 1 10 Assay Diluent B Mouse SDF-1-alpha concentration (pg/mL) 1 10 100 1000 O D =4 50 n m 0.01 0.1 1 10
Sensitivity: The minimum detectable dose of SDF-1alpha is typically less than 3 pg/mL.
Recovery: Recovery was determined by spiking various levels of mouse SDF-1alpha into mouse serum, plasma and cell culture media. Mean recoveries are as follows: Sample Type Average % Recovery Range ( %) Serum 98.76 88-106 Plasma 100.36 90-107 Cell culture media 99.34 89-107
Linearity: Sample Type Serum Plasma Cell Culture Media 1:2 Average % of Expected 99 99 98 Range ( %) 91-107 89-106 88-106 1:4 Average % of Expected 97 98 96 Range ( %) 91-107 89-106 91-108
Reproducibility: Intra-Assay: CV<10 % Inter-Assay: CV<12 % - Précision du teste
- Intra-Assay: CV< 10 % Inter-Assay: CV< 12 %
- Restrictions
- For Research Use only
-
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- The entire kit may be stored at -20°C for up to 1 year from the date of shipment. Avoid repeated freeze-thaw cycles. The kit may be stored at 4°C for up to 6 months. For extended storage, it is recommended to store at -80°C.
- Date de péremption
- 6 months
-
-
Repairing sciatic nerve injury with an EPO-loaded nerve conduit and sandwiched-in strategy of transplanting mesenchymal stem cells." dans: Biomaterials, Vol. 142, pp. 90-100, (2018) (PubMed).
: "Cyclooxygenase-2 or tumor necrosis factor-? inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic ..." dans: Stem cells (Dayton, Ohio), Vol. 33, Issue 4, pp. 1173-86, (2015) (PubMed).
: "Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice." dans: Stem cells (Dayton, Ohio), Vol. 33, Issue 4, pp. 1241-53, (2015) (PubMed).
: "Myelopoiesis is regulated by osteocytes through Gs?-dependent signaling." dans: Blood, Vol. 121, Issue 6, pp. 930-9, (2013) (PubMed).
: "Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis." dans: Stem cells (Dayton, Ohio), Vol. 31, Issue 7, pp. 1321-9, (2013) (PubMed).
: "Loss of SPARC in bladder cancer enhances carcinogenesis and progression." dans: The Journal of clinical investigation, Vol. 123, Issue 2, pp. 751-66, (2013) (PubMed).
: "Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction." dans: Physiological research, Vol. 61, Issue 5, pp. 543-9, (2013) (PubMed).
: "Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy." dans: Leukemia research, Vol. 37, Issue 5, pp. 503-9, (2013) (PubMed).
: "miR-27b represses migration of mouse MSCs to burned margins and prolongs wound repair through silencing SDF-1a." dans: PLoS ONE, Vol. 8, Issue 7, pp. e68972, (2013) (PubMed).
: "Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis." dans: Circulation research, Vol. 110, Issue 3, pp. 428-38, (2012) (PubMed).
: "Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells." dans: British journal of pharmacology, Vol. 167, Issue 7, pp. 1506-19, (2012) (PubMed).
: "Early sensing of Yersinia pestis airway infection by bone marrow cells." dans: Frontiers in cellular and infection microbiology, Vol. 2, pp. 143, (2012) (PubMed).
: "microRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1αin vitro." dans: Biochemical and biophysical research communications, Vol. 421, Issue 2, pp. 389-95, (2012) (PubMed).
: "Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells." dans: Glia, Vol. 59, Issue 1, pp. 108-18, (2011) (PubMed).
: "Cardiac progenitor cell commitment is inhibited by nuclear Akt expression." dans: Circulation research, Vol. 108, Issue 8, pp. 960-70, (2011) (PubMed).
: "A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)" dans: The Journal of experimental medicine, Vol. 184, Issue 3, pp. 1101-9, (1997) (PubMed).
: "Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene." dans: Genomics, Vol. 28, Issue 3, pp. 495-500, (1996) (PubMed).
: "Emergency response to nuclear and radiation accidents." dans: Bone marrow transplantation, Vol. 4 Suppl 4, pp. 2-3, (1990) (PubMed).
: "
-
Repairing sciatic nerve injury with an EPO-loaded nerve conduit and sandwiched-in strategy of transplanting mesenchymal stem cells." dans: Biomaterials, Vol. 142, pp. 90-100, (2018) (PubMed).
-
- Antigène Voir toutes CXCL12 Kits ELISA
- CXCL12 (Chemokine (C-X-C Motif) Ligand 12 (CXCL12))
- Autre désignation
- SDF-1 alpha (CXCL12 Produits)
- Synonymes
- IRH Kit ELISA, PBSF Kit ELISA, SCYB12 Kit ELISA, SDF1 Kit ELISA, TLSF Kit ELISA, TPAR1 Kit ELISA, CINC-1 Kit ELISA, Gro1 Kit ELISA, Pbsf Kit ELISA, Scyb12 Kit ELISA, Sdf1 Kit ELISA, Tlsf Kit ELISA, Tpar1 Kit ELISA, Fsp Kit ELISA, KC Kit ELISA, Mgsa Kit ELISA, N51 Kit ELISA, Scyb1 Kit ELISA, gro Kit ELISA, sdf-1 Kit ELISA, sdf1 Kit ELISA, xSDF-1 Kit ELISA, SDF-1 Kit ELISA, cxcl12 Kit ELISA, sdf-1a Kit ELISA, sdf1a Kit ELISA, wu:fa55e10 Kit ELISA, wu:fc16h12 Kit ELISA, wu:fj84c02 Kit ELISA, C-X-C motif chemokine ligand 12 Kit ELISA, C-X-C motif chemokine ligand 1 Kit ELISA, chemokine (C-X-C motif) ligand 12 Kit ELISA, chemokine (C-X-C motif) ligand 1 Kit ELISA, C-X-C motif chemokine ligand 12 L homeolog Kit ELISA, chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1) Kit ELISA, CXCL12 Kit ELISA, cxcl12 Kit ELISA, Cxcl1 Kit ELISA, Cxcl12 Kit ELISA, cxcl12.L Kit ELISA, cxcl12a Kit ELISA
- Sujet
- Stromal cell-derived factor 1 (SDF-1) (12-O-tetradecanoylphorbol 13-acetate repressed protein 1) (TPAR1) (C-X-C motif chemokine 12) (Pre-B cell growth-stimulating factor) (PBSF) (Thymic lymphoma cell-stimulating factor) (TLSF)
- ID gène
- 20315
- UniProt
- P40224
- Pathways
- Regulation of Cell Size, CXCR4-mediated Signaling Events, Negative Regulation of intrinsic apoptotic Signaling
-